Picture of Kainos Laboratories logo

4556 Kainos Laboratories Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousMicro CapContrarian

Annual cashflow statement for Kainos Laboratories, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line599613767845930
Depreciation
Non-Cash Items18.947.112.410.91.53
Unusual Items
Other Non-Cash Items
Changes in Working Capital-75.5-211-325-453-620
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities678591604545431
Capital Expenditures-55.1-73.2-141-7.7-75.7
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items2.91-44-0.017-2.632.88
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-52.2-117-141-10.3-72.8
Financing Cash Flow Items-0.001-0.001-0.001-0.001
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities386-195-31.3-191-204
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1,011280433343154